Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;196(5):417-420.
doi: 10.1007/s00066-020-01603-1.

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

Matthias Guckenberger  1 , Wolfgang W Baus  2 , Oliver Blanck  3 , Stephanie E Combs  4 , Jürgen Debus  5 , Rita Engenhart-Cabillic  6 , Tobias Gauer  7 , Anca L Grosu  8 , Daniela Schmitt  5 , Stephanie Tanadini-Lang  1 , Christos Moustakis  9
Affiliations
Review

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

Matthias Guckenberger et al. Strahlenther Onkol. 2020 May.

Abstract

Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.

Keywords: Definition; Radiosurgery; SBRT; SRS; Stereotactic Body Radiotherapy.

PubMed Disclaimer

Conflict of interest statement

M. Guckenberger, W.W. Baus, O. Blanck, S.E. Combs, J. Debus, R. Engenhart-Cabillic, T. Gauer, A.L. Grosu, D. Schmitt, S. Tanadini-Lang and C. Moustakis declare that they have no competing interests.

References

    1. Guckenberger M, Andratschke N, Alheit H, et al. Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol. 2014;190(1):26–33. doi: 10.1007/s00066-013-0450-y. - DOI - PMC - PubMed
    1. Kocher M, Wittig A, Piroth MD, et al. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2014;190(6):521–532. doi: 10.1007/s00066-014-0648-7. - DOI - PubMed
    1. Sterzing F, Brunner TB, Ernst I, et al. Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on Stereotactic radiotherapy. Strahlenther Onkol. 2014;190(10):872–881. doi: 10.1007/s00066-014-0714-1. - DOI - PubMed
    1. Panje C, Andratschke N, Brunner TB, et al. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer: literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2016;192(12):875–885. doi: 10.1007/s00066-016-1053-1. - DOI - PubMed
    1. Guckenberger M, Andratschke N, Dieckmann K, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol. 2017;124(1):11–17. doi: 10.1016/j.radonc.2017.05.012. - DOI - PubMed

LinkOut - more resources